4/A: Personalis Director Karin Eastham Corrects RSU Filing

Director Karin Eastham filed an amendment to correct the reported beneficial ownership of common stock following an RSU grant.

Summary

• Director Karin Eastham received a grant of 6,250 restricted stock units (RSUs) on May 12, 2026.
• The filing serves as an amendment to a previously submitted Form 4 dated May 14, 2026, to correct the total beneficial ownership count.
• The updated total beneficial ownership for the director is 19,756 shares of common stock.
• The RSUs vest on the earlier of the one-year anniversary of the grant or the day prior to the next annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding director compensation and a correction of a clerical error.

Positives

• Director alignment with shareholder interests through equity-based compensation.

Negatives

• Administrative error in the original filing necessitated an amendment.

Risks

• Vesting is subject to the director's continuous service through the vesting date.

Future Outlook

The RSUs are scheduled to vest on the earlier of the one-year anniversary of the grant date or the day prior to the company's next annual meeting of stockholders.

Management Comments

• Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Industry Context

StockSavvy.ai notes that director equity grants are standard practice in the biotechnology and genomics sector to ensure long-term alignment between board members and company performance.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard corporate governance practices for mid-cap biotech firms.
• Vesting schedules tied to annual meetings are common among peer companies in the life sciences industry.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine director compensation disclosure.

Next Steps

• Vesting of the 6,250 RSUs upon the earlier of the one-year anniversary or the next annual meeting.

Key Dates

Keywords

Personalis, PSNL, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan